logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Radiotherapy and Oncology cover

Radiotherapy and Oncology

IF5.3
Papers21420
Citations23597
Journal Papers 47790
Publication Date
delete
Early target volume dynamics during MR-guided radiotherapy for glioblastoma: first results from the prospective MARGA-I trial
deleteRadiotherapy and Oncology
IF5.3
delete2026-10-04
delete0
deleteOAAI
deleteLena Kretzschmar; Philipp Wallimann; Lena M. Obergfell; Stephanie Tanadini-Lang; Bertrand Pouymayou; Andreas Boss; Sylwia Nowakowska; Andrea Bink; Matthias Guckenberger; Michael Mayinger; Sebastian M. Christ; Nicolaus Andratschke
deleteShare
deleteSave
Stereotactic MRI-guided adaptive radiation therapy (SMART) for locally advanced pancreatic cancer: A prospective single-center cohort study
deleteRadiotherapy and Oncology
IF5.3
delete2026-10-01
delete0
deleteOAAI
deletePia Braagaard Hartfelt; Anne L.H. Bisgaard; Mathilde Weisz Ejlsmark; Rana Bahij; Tine Schytte; Faisal Mahmood; Per Pfeiffer; Uffe Bernchou
deleteShare
deleteSave
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-30
delete0
PREAI
deleteDamien J. McHugh; Martin Swinton; Claire A. Hart; Diego Sanchez Martinez; Chris Moore; Jeremy Oates; Maurice Lau; Vijay Ramani; Ashwin Sachdeva; Noel Clarke; David L. Buckley; Marcel van Herk; Andrew Hudson; Ananya Choudhury; Robert G. Bristow; Michael J. Dubec
deleteShare
deleteSave
The European particle therapy network at 10 years: milestones achieved and the road ahead
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-30
delete0
deleteOAAI
deleteDamien C. Weber; Johannes A. Langendijk; Sairos Safai; Oliver Jäkel; Stefano Lorentini; Morten Høyer; Markus Stock; Alessandra Bolsi; Christian Richter; Tony Lomax; Brita Singers Sørensen; Yolande Lievens; Hedwig M. Blommestein; Esther G.C. Troost; Rita Simoes; Francesca Albertini; Pieter Populaire; Armin Lühr; Dietmar Georg; Cai Grau
deleteShare
deleteSave
Optimising proton therapy referral pathways for lung and oesophageal cancer in a Dutch interorganisational referral network: A canonical action research study
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-27
delete0
deleteOAAI
deleteFiona Ho; Maria Jacobs; Luca Heising; Paul Cremers; Carol Ou; Bert Meijboom; Liesbeth Boersma
deleteShare
deleteSave
Population-based analysis of single-fraction versus multi-fraction stereotactic ablative radiotherapy for early-stage non-small cell lung cancer
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-26
delete0
PREAI
deleteKaren Anne Aguirre-Meneses; Sarah Baker; Jose Miguel Callueng; Nick Chng; David Petrik; Emma Maria Dunne; Siavash Atrchian; Angela Lin; Allison Ye; Chad Lund; Katie Jasper; Thomas Kennedy; Fred Hsu; Devin Schellenberg; Mitchell Liu; Benjamin Mou
deleteShare
deleteSave
Influence of dosimetry on outcomes in HDR prostate brachytherapy monotherapy
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-26
delete0
PREAI
deletePooriwat Muangwong; Peter Ostler; Mohammed Abdul-Latif; Peter Hoskin
deleteShare
deleteSave
De-escalating elective nodal irradiation dose to 45 Gy in nasopharyngeal carcinoma: A large-cohort study with 5-year outcomes
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-25
delete0
PREAI
deleteXinlan Chen; Yuan Huang; Kexin Lin; Jihong Chen; Yedong Huang; Yahan Zheng; Hanchuan Xu; Ziyi Wu; Xinping Chen; Jingfeng Zong; Chaobin Huang; Jianji Pan; Shaojun Lin; Qiaojuan Guo
deleteShare
deleteSave
LINACS: an ESTRO/OligoCare living systematic review of the safety of concurrent stereotactic radiotherapy and novel systemic therapies (version 1)
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-23
delete0
PREAI
deleteNora Sundahl; Esmée Lauren Looman; Luc Ollivier; Matteo Bagnalasta; Piet Ost; Matthias Guckenberger; Jeffrey Ryckman; Matthew Culbert; Geertruida Bekkering; Sabrina Reichl
deleteShare
deleteSave
Dosimetric correlation of radiation-induced chronic kidney disease (CKD): a competing risks analysis
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-23
delete0
PREAI
deleteYu-Ming Wang; Chung-Shih Chen; Jen-Yu Cheng; Chong-Jong Wang; Eng-Yen Huang
deleteShare
deleteSave
Stereotactic ablative radiotherapy for oligometastatic breast cancer: A systematic review and meta-analysis (SABRINA)
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-20
delete0
PREAI
deleteGustavo A. Viani; Ana Carolina Hamamura; Caio Viani Arruda; Carlos E. Cardoso; Helio A. Salmon; Gustavo O. Amaral
deleteShare
deleteSave
Impact of accumulated target dose on tumor response in distal esophageal cancer treated with intensity-modulated proton therapy
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-19
delete0
PREAI
deleteKyra van Keeken; Vlad Badiu; Gloria Vilches-Freixas; Jeroen Buijsen; Bastiaan Ta; Britt Hupkens; Inge Steenbakkers; Valery Lemmens; Richard Canters; Maaike Berbée
deleteShare
deleteSave
Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-19
delete0
PREAI
deleteXiaolong Wang; Xinrui Yu; Xiaoli Liu; Kaikai Zhao; Yankang Li; Hong Feng; Meili Sun; Jinming Yu; Yu Chen; Xiangjiao Meng
deleteShare
deleteSave
Corrigendum to “Impact of oxygen deprivation on the FLASH effect for skin toxicity in a murine model” [Radiother. Oncol. 214 (2026) 111277]
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-18
delete0
deleteOAAI
deleteAnna Holtz Hansen; Per Rugaard Poulsen; Line Kristensen; Valentin Vacari Møller; Priyanshu M. Sinha; Jacob Graversen Johansen; Brita Singers Sørensen
deleteShare
deleteSave
Corrigendum to “Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol” [Radiother. Oncol. 223 (2026) 111717]
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-16
delete0
PREAI
deleteRichard Canters; Vlad Badiu; Dominique Reijtenbagh; Esther Kneepkens; Gloria Vilches-Freixas; Maaike Berbee
deleteShare
deleteSave
Clinical outcomes among patients treated with Lu-PSMA-617 and metastasis-directed EBRT for metastatic prostate cancer
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-15
delete0
PREAI
deleteElio Adib; Emerson Lee; Yu-Hui Chen; Kirti Menon; Joseph H. Killoran; Hailey Stoltenberg; Heather Jacene; Praful Ravi; Mai Anh Huynh
deleteShare
deleteSave
Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-15
delete0
deleteOAAI
deleteYasir Alayed; Andrew Loblaw; Lucas C. Mendez; Rohann J.M. Correa; Aneesh Dhar; David Laidley; Andrew Warner; Hatim Fakir; Matt Wronski; John Conyngham; Zahra Kassam; Joelle Helou; David P. D’Souza; Vikram Velker; Michael Lock; Belal Ahmad; Glenn S. Bauman
deleteShare
deleteSave
Patient-clinician symptom agreement before and after radiotherapy for prostate cancer: results from the randomized HYPO-RT-PC study
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-13
delete0
deleteOAAI
deleteUlrika Rönningås; Lars Beckman; Anna-Karin Wennstig; Per Fransson
deleteShare
deleteSave
Risk and prognostic survival analysis of radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma: intensity-modulated radiotherapy and two-dimensional radiotherapy
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-13
delete0
PREAI
deleteRenyuan Huang; Jiahao Lou; Chenghao Li; Zhen Xu; Qingqing Xu; Yuntong Zhou; Weijie Cai; Ling Ye; Lulu Zhang; Mian Xi; Lei Chen
deleteShare
deleteSave
Testosterone monitoring and supplementation in patients with intermediate- or high-risk prostate cancer treated with 6–36 months of androgen deprivation therapy and radiotherapy: a systematic literature review
deleteRadiotherapy and Oncology
IF5.3
delete2026-09-12
delete0
PREAI
deleteVérane Achard; Almuneda Zapatero; Amar U. Kishan; Pierre Blanchard; Lisa G. Horvath; Barbara A. Jereczek-Fossa; Bertrand Tombal
deleteShare
deleteSave